aod9604 2mg AOD-9604 – Research Peptide AOD-9604 – Power Peptides

The MHRA ( Medicines and Healthcare products Regulatory Agency ) has two main application procedures: Simple Reclassification : This is a straightforward and quick procedure based on an analogous product (a medicinal product already on the UK market with the same active ingredient, route of administration, use, and a similar or higher strength/dosage)

By combining NAD, MOTS-C, and 5-Amino-1MQ into a single formulation, Metabolic Blend serves as a valuable research tool for investigating pathway convergence, cellular energy regulation, and coordinated metabolic signaling within controlled laboratory environments

In a pilot trial of NAD+ intravenous infusion in healthy adults, subjects receiving 750 mg of NAD+ over 6 hours reported no negative symptoms at all, and there were no vital sign abnormalities or serious laboratory derangements compared to placebo

Not yet a patient

Storage & Stability Before Use : Store the sealed bottle in a cool, dry, and dark environment at room temperature (1525 C / 5977 F)